Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Alberta Infant Motor Scale (AIMS)

Aug 28, 2017/Test & Measure

Assesses gross infant motor skills from ages 0 to 18 months.

Geriatric Depression Scale (GDS)

Jun 6, 2019/Test & Measure

Measures depression and suicidal ideation in elderly people.

Takeaways From the Proposed 2023 Medicare Physician Fee Schedule, Part 1

Jul 11, 2022/News

A cut to the conversion factor, no changes to telehealth limitations (but a few codes added), a tweak to RVUs, and more.

Breaking Through Four Barriers to Better Addressing Men's Pelvic Health Needs

Jun 13, 2022/Perspective

Men’s pelvic health is too often overlooked both by patients and physical therapists.

Facing Challenges With MIPS Reporting Requirements? Exceptions Are Available

Aug 6, 2024/Article

CMS’ Quality Payment Program offers exceptions to MIPS reporting requirements for certain hardships and uncontrollable circumstances. To be eligible, you must apply by Dec. 31.

Education Leadership Partnership

Dec 22, 2021/Article

The Education Leadership Partnership, a collaboration between APTA, ACAPT, and the Academy of Education, completed its charge with the published report "A Vision of Excellence in Physical Therapy Education."

CMS Listens to APTA, Eases Code Restrictions for Manual Therapy and Compression

Jan 5, 2022/News

APTA continues to advocate for changes that reflect the realities of physical therapy and patient-centered care.

Listen Up! Four Recent APTA Podcasts Worth Checking Out

Oct 30, 2023/Roundup

Learn about a landmark APTA report, explore APTA's new research agenda, share in one PT's professional journey, and more.

APTA Wins AMA Award for Education on Caregiver Training Codes

Apr 2, 2024/News

After helping create the CPT codes and advocate for their adoption, APTA launched an education campaign featuring a practice advisory.

IMPROVE VTE Risk Model

Oct 31, 2021/Test & Measure

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1